DK207279A - Fremgangsmaade til fremstilling af e-vitaminpulver - Google Patents

Fremgangsmaade til fremstilling af e-vitaminpulver

Info

Publication number
DK207279A
DK207279A DK207279A DK207279A DK207279A DK 207279 A DK207279 A DK 207279A DK 207279 A DK207279 A DK 207279A DK 207279 A DK207279 A DK 207279A DK 207279 A DK207279 A DK 207279A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
vitamin powder
vitamin
powder
Prior art date
Application number
DK207279A
Other languages
English (en)
Other versions
DK156696B (da
DK156696C (da
Inventor
A Kuipers
H Becker
H Tiefenbacher
H Schumacher
Original Assignee
Basf Ag
Meggle Milchind Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Meggle Milchind Gmbh & Co filed Critical Basf Ag
Publication of DK207279A publication Critical patent/DK207279A/da
Publication of DK156696B publication Critical patent/DK156696B/da
Application granted granted Critical
Publication of DK156696C publication Critical patent/DK156696C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
DK207279A 1978-05-22 1979-05-21 Fremgangsmaade til fremstilling af e-vitamin-toerpulver DK156696C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2822324A DE2822324C3 (de) 1978-05-22 1978-05-22 Herstellung von Vitamin-E-Trockenpulver
DE2822324 1978-05-22

Publications (3)

Publication Number Publication Date
DK207279A true DK207279A (da) 1979-11-23
DK156696B DK156696B (da) 1989-09-25
DK156696C DK156696C (da) 1990-02-05

Family

ID=6039954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK207279A DK156696C (da) 1978-05-22 1979-05-21 Fremgangsmaade til fremstilling af e-vitamin-toerpulver

Country Status (4)

Country Link
US (1) US4262017A (da)
EP (1) EP0005529B1 (da)
DE (2) DE2822324C3 (da)
DK (1) DK156696C (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062867D1 (en) * 1980-04-01 1983-06-01 Sumitomo Chemical Co Process for the production of water-soluble biotin-containing preparations and their use as additives to feed supplements
US4395422A (en) * 1981-04-06 1983-07-26 Basf Wyandotte Corporation Spray dried vitamin E powder
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
US4617294A (en) * 1985-04-22 1986-10-14 Ppg Industries, Inc. Animal feed supplement
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8075872B2 (en) * 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) * 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
PE20050728A1 (es) * 2003-08-06 2005-11-10 Gruenenthal Chemie Forma de dosificacion a prueba de abuso
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2643546A1 (en) * 2006-02-21 2007-08-30 The Ohio State University Research Foundation Anticancer agents
WO2007143081A2 (en) * 2006-06-02 2007-12-13 The Ohio State University Research Foundation Therapeutic agents for the treatment of lymphoid malignancies
DE102007011485A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5774853B2 (ja) * 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
TWI524904B (zh) * 2008-05-09 2016-03-11 歌林達股份有限公司 製備醫藥用固體劑型，尤指錠劑之方法，及製備固體劑型，尤指錠劑之前驅物之方法
CA2758823A1 (en) * 2009-04-13 2010-10-21 The Ohio State University Research Foundation Protein phosphatase 2a-activating agents
WO2010121111A1 (en) * 2009-04-17 2010-10-21 The Ohio State University Research Foundation Antiadhesion agents
JP2012533586A (ja) * 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化安定化された不正使用防止剤形
CA2765971C (en) 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
ES2606227T3 (es) * 2010-02-03 2017-03-23 Grünenthal GmbH Preparación de una composición farmacéutica en polvo mediante una extrusora
NZ608865A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising an anionic polymer
AU2011297901B2 (en) 2010-09-02 2014-07-31 Grunenthal Gmbh Tamper resistant dosage form comprising inorganic salt
WO2012074960A2 (en) 2010-11-29 2012-06-07 The Ohio State University Research Foundation Fty720-derived anticancer agents
PT2736497T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
CN103841964A (zh) 2011-07-29 2014-06-04 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
CN105592724B (zh) 2013-08-29 2019-01-18 雅培公司 具有提高的溶解度和生物利用度的亲脂性化合物的营养组合物
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
EA035434B1 (ru) 2015-04-24 2020-06-15 Грюненталь Гмбх Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
MX2018001225A (es) 2015-07-29 2018-05-22 Abbott Lab Productos nutricionales con biodisponibilidad y solubilidad lipofilica mejoradas en una forma facil de mezclar.
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE640508A (da) *
US3124510A (en) * 1964-03-10 Stable dry powdered fat-soluble
DE1098798B (de) * 1958-06-27 1961-02-02 Albert Fricke Mastfuttermittel aus frischer oder getrockneter Voll- oder Magermilch
GB919193A (en) * 1958-11-12 1963-02-20 Shinshiro Ohtaki A method for producing powder containing oil or fat
GB1147210A (en) * 1965-06-30 1969-04-02 Eastman Kodak Co Improvements in or relating to vitamins
US3446899A (en) * 1968-01-25 1969-05-27 Hoffmann La Roche Vitamin compositions produced by direct compression
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder
US3914430A (en) * 1972-04-10 1975-10-21 Hoffmann La Roche Free-flowing, high density, agglomerated vitamin E powder compositions
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5421403B2 (da) * 1974-01-18 1979-07-30

Also Published As

Publication number Publication date
EP0005529B1 (de) 1981-01-07
DE2822324C3 (de) 1981-02-26
US4262017A (en) 1981-04-14
EP0005529A1 (de) 1979-11-28
DE2822324B2 (de) 1980-06-19
DK156696B (da) 1989-09-25
DK156696C (da) 1990-02-05
DE2822324A1 (de) 1979-11-29
DE2960122D1 (en) 1981-02-26

Similar Documents

Publication Publication Date Title
DK207279A (da) Fremgangsmaade til fremstilling af e-vitaminpulver
DK149023C (da) Analogifremgangsmaade til fremstilling af tiazolidinderivater
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK294880A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK413780A (da) Fremgangsmaade til fremstilling af d-6-n-propylergoliner
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK147145C (da) Analogifremgangsmaade til fremstilling af chlorambucilderivater
DK161198C (da) Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK177680A (da) Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK157850C (da) Fremgangsmaade til fremstilling af 7-acylindolin-2-oner
DK147183C (da) Fremgangsmaade til fremstilling af l-alfa-glycerophosphatoxidase
DK250679A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin
DK12879A (da) R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate
DK12379A (da) Fremgangsmaade til fremstilling af cysteinholdige peptider
DK362379A (da) Fremgangsmaade til fremstilling af alfa-alkyl-o-oxybenzylaminderivater

Legal Events

Date Code Title Description
PUP Patent expired